Treatment of Drug-Resistant Tuberculosis

Details

• Alternative Title:
  Clin Chest Med
• Personal Author:
  Mase, Sundari R. ; Chorba, Terence
• Description:
  The treatment of drug-resistant tuberculosis (TB) is complicated and has evolved significantly in the past decade with the advent of rapid molecular tests and updated evidence-based guidelines of the World Health Organization and other organizations. The latest recommendations incorporate the use of new drugs and regimens that maximize efficacy and minimize toxicity to improve treatment outcomes for the patients. This article provides an overview of the latest published strategies for clinical and programmatic management of drug-resistant TB.
• Subjects:
  Antitubercular Agents Humans Treatment Outcome Tuberculosis, Multidrug-Resistant World Health Organization
• Keywords:
  Adverse Drug Reactions Drug Resistance Management Regimen Treatment Tuberculosis
• Source:
  Clin Chest Med. 40(4):775-795
• Pubmed ID:
  31731984
• Pubmed Central ID:
  PMC7000172
• Document Type:
  Journal Article
• Funding:
  001/WHO_/World Health OrganizationInternational/ ; CC999999/Intramural CDC HHSUnited States/
• Volume:
  40
• Issue:
  4
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha256:c28d42f287c54e18e0eb93a972d638e71e7d095f3b0cd00bd03a116002cec066
• Download URL:
  https://stacks.cdc.gov/view/cdc/84935/cdc_84935_DS1.pdf
• File Type:
  [PDF - 708.64 KB ]